Clinical Trial Update: Non-interventional Study of Risperidone ISM® in Schizophrenia Patients Hospitalised Due to a Relapse

View source ↗

Summary

A completed non-interventional study assessing risperidone ISM in schizophrenia patients hospitalized due to relapse.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Risperidone ISM (risperidone)

Snippet

Sponsor: Rovi Pharmaceuticals Laboratories | Conditions: Schizophrenia | Status: COMPLETED